Does surgery still have a role in stage III NSCLC in the era of immunotherapy? The surgeon’s view

Date 29 September 2019
Event ESMO 2019 Congress
Session Immunotherapy in thoracic malignancies: What has been achieved in 2019?
Topics Non-Small Cell Lung Cancer
Surgical Oncology
Thoracic Malignancies
Presenter Ad Verhagen
Authors A. Verhagen
  • Cardio-thoracic Surgery, Radboud University Medical Center, 6525 GA - Nijmegen/NL